NBT Bancorp NBTB Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount

Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount at other companies

AbCellera Biologics Inc.ABCL

$50K-98.8%

BKBK

$0—

BKBK

$394M+13.2%

PayPal Holdings, Inc.PYPL

$68M—

Rockwell AutomationROK

$23M0.0%

CitigroupC

$1.74B+12.8%

Other financials

Income statement

See full

Revenue$184.5M+19.3%

Net income$51.1M+39.2%

EPS (diluted)$0.98+27.3%

Balance sheet

See full

Cash & equivalents$716.1M+182%

Total debt$117.8M+37.6%

Total equity$1.9B+22.3%

Total assets$16.2B+16.9%

Cash flow

See full

Operating cash flow$53.0M+26.3%

CapEx$4.4M+19.5%

Free cash flow$48.6M+26.9%

Valuation

See full

Market cap$2.5B+9.7%

Enterprise value$1.9B-12.6%

P/E13.6×-2.3×

P/S3.4×-0.4×

Profitability

See full

Net margin25.3%+1.0pp

FCF margin31.5%+0.9pp

Returns & leverage

See full

Return on equity10.6%+1.0pp

Debt / equity0.1×0.0×

Where this comes from

Reported directly by NBT Bancorp in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount.

The official record: NBT Bancorp’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NBT Bancorp's equity securities without readily determinable fair value, upward price adjustment, annual amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NBT Bancorp's equity securities without readily determinable fair value, upward price adjustment, annual amount?: NBT Bancorp (NBTB) reported equity securities without readily determinable fair value, upward price adjustment, annual amount of $0 in Q1 2026.